Skip to content

Lucid Diagnostics LUCD Accounts Receivable

Accounts Receivable at other companies

Castle Biosciences logo
Castle BiosciencesCSTL
$42.26M-25.0%
Guardant Health logo
Guardant HealthGH
$137.4M+19.0%
Biodesix, Inc. logo
Biodesix, Inc.BDSX
$9.5M+24.4%
Insight Molecular Diagnostics Inc. Common Stock logo
Insight Molecular Diagnostics Inc. Common StockIMDX
$157K-95.6%
Fulgent Genetics, Inc. logo
Fulgent Genetics, Inc.FLGT
$69.28M-3.1%
Personalis, Inc. logo
Personalis, Inc.PSNL
$13.02M+18.7%

Other financials

Income statement

See full
Revenue$1.3M+51.7%
Gross profit-$369.0K+49.0%
Operating income-$12.1M+3.0%
Net income-$13.9M+48.3%
EPS (diluted)-$0.10+60.0%

Balance sheet

See full
Cash & equivalents$27.9M+10.6%
Total debt$1.6M-35.1%
Total equity$4.0M+174%
Total assets$34.1M+3.9%

Cash flow

See full
Operating cash flow-$12.1M+2.9%
CapEx$215.0K+131%
Free cash flow-$12.3M+1.9%

Valuation

See full
Market cap$204.13M+58.5%
Enterprise value$177.85M+78.0%
P/S39.8×+10.2×

Profitability

See full
Gross margin-66.8%
Operating margin-959.6%-133pp
Net margin-876.7%-254pp
FCF margin-1,099.6%

Returns & leverage

See full
Return on equity-710.6%
Debt / equity0.4×
Current ratio1.1×+0.3×

Where this comes from

Reported directly by Lucid Diagnostics in its filing.

Tagged under the XBRL concept us-gaap:AccountsReceivableNetCurrent.

The official record: Lucid Diagnostics’s 10-Q, filed May 13, 2026, on SEC EDGAR. View the filing →

Ask your AI about Lucid Diagnostics's accounts receivable.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is Lucid Diagnostics's accounts receivable?
Lucid Diagnostics (LUCD) reported accounts receivable of $689K in Q1 2026.
How has Lucid Diagnostics's accounts receivable changed year-over-year?
Lucid Diagnostics's accounts receivable increased by 1029.5% year-over-year, from $61K to $689K.
What is the long-term trend for Lucid Diagnostics's accounts receivable?
Over 4 years (2021 to 2025), Lucid Diagnostics's accounts receivable has grown at a 34.3% compound annual growth rate (CAGR), from $500K to $1.63M.
What does accounts receivable mean?
Amounts owed by customers for goods delivered or services performed, net of allowances for doubtful accounts. A key working capital component.